Empyrean Capital Partners, LP AMPHASTAR PHARMACEUTICALS IN Transaction History
Empyrean Capital Partners, LP
- $2.57 Billion
- Q2 2025
Number of Shares
15,000,000
Previous 17,000,000
11.76%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%